Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
Analyst Buy
|
Expensive Star
6600.5000
-42.00
(
-0.63
%)
NSE
Jan 08, 2026
15:31 PM
33.21% Gain from 52W Low
Volume:
331.5K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
03 Oct 2022
Analyst Buy
6600.50
-0.63%
Ashika - Stock Picks Divi's Laboratories Ltd. - October 2022
Buy:
Divi's Laboratories Ltd.
by
Ashika Research
Target: 4110
Target
Ashika Research
Number of FII/FPI investors decreased from 990 to 897 in Sep 2025 qtr
More from Divi's Laboratories Ltd.
Recommended
Market closes lower, amid foreign fund outflows & US tariff threats on Russian energy buyers
Trendlyne Marketwatch |
08 Jan 2026, 03:59PM
Don't be boring, unless you are an investor
The Baseline |
07 Jan 2026, 07:39PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022